These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7963958)
21. [Diagnosis and treatment for aplastic anemia]. Usuki K Rinsho Ketsueki; 2021; 62(8):922-930. PubMed ID: 34497232 [TBL] [Abstract][Full Text] [Related]
22. Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic anemia in children. A pilot study. Matloub YH; Bostrom B; Golembe B; Priest J; Ramsay NK Am J Pediatr Hematol Oncol; 1994 May; 16(2):104-6. PubMed ID: 8166362 [TBL] [Abstract][Full Text] [Related]
23. Diagnosis and treatment of acquired aplastic anemia. Bacigalupo A; Passweg J Hematol Oncol Clin North Am; 2009 Apr; 23(2):159-70. PubMed ID: 19327577 [TBL] [Abstract][Full Text] [Related]
24. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia. Vadhan-Raj S Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150 [No Abstract] [Full Text] [Related]
25. [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia]. Zheng Y; Chu Y; Shao Z Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):175-7. PubMed ID: 11601221 [TBL] [Abstract][Full Text] [Related]
26. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]. Kitamura K; Asano S; Mizoguchi H; Takaku F Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327 [TBL] [Abstract][Full Text] [Related]
28. Effects of haemopoietic growth factors for aplastic anaemia. Foot AB; Potter MN; Mott MG; Oakhill A Lancet; 1994 Sep; 344(8924):757. PubMed ID: 7915805 [No Abstract] [Full Text] [Related]
29. New approach of treatment of severe aplastic anemia. Cooperative Group on the Treatment of Aplastic Anemia. Gluckman E; Bourdeau-Esperou H; Boogaerts M; Briere J; Navarro J; Leverger G; Leporrier M; Reiffers J; Janvier M; Michallet M Bone Marrow Transplant; 1991; 7 Suppl 2():106-7. PubMed ID: 1878666 [No Abstract] [Full Text] [Related]
30. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response. Vadhan-Raj S; Broxmeyer HE; Hittelman WN Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234 [No Abstract] [Full Text] [Related]
31. Treatment of acquired severe aplastic anemia. Katsanis E; Ramsay NK Am J Pediatr Hematol Oncol; 1989; 11(3):360-7. PubMed ID: 2675662 [TBL] [Abstract][Full Text] [Related]
32. Aplastic anemia following hepatitis associated with human herpesvirus 6. Schenke C; Alejandre-Alcázar MA; Holter W; Korn K; Papadopoulos T; Köhler H J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):527-9. PubMed ID: 20706145 [No Abstract] [Full Text] [Related]
33. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor. Bezwoda WR; Dajee D Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094 [TBL] [Abstract][Full Text] [Related]